| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Depression | 15 | 2026 | 507 | 2.470 |
Why?
|
| Suicide | 10 | 2024 | 116 | 1.950 |
Why?
|
| Depressive Disorder | 15 | 2026 | 186 | 1.580 |
Why?
|
| Adolescent | 54 | 2026 | 3625 | 1.490 |
Why?
|
| Health Care Costs | 9 | 2022 | 211 | 1.480 |
Why?
|
| Autism Spectrum Disorder | 8 | 2024 | 164 | 1.460 |
Why?
|
| Behavior Therapy | 7 | 2026 | 125 | 1.380 |
Why?
|
| Depressive Disorder, Major | 7 | 2022 | 98 | 1.360 |
Why?
|
| Anxiety | 7 | 2026 | 162 | 1.350 |
Why?
|
| Humans | 101 | 2026 | 17622 | 1.340 |
Why?
|
| Anxiety Disorders | 10 | 2026 | 100 | 1.250 |
Why?
|
| Female | 77 | 2026 | 12715 | 1.210 |
Why?
|
| Primary Health Care | 10 | 2026 | 729 | 1.200 |
Why?
|
| Male | 68 | 2026 | 10014 | 1.180 |
Why?
|
| Mental Health Services | 12 | 2019 | 155 | 1.120 |
Why?
|
| Cost-Benefit Analysis | 9 | 2026 | 237 | 1.120 |
Why?
|
| Patient Acceptance of Health Care | 8 | 2022 | 380 | 1.030 |
Why?
|
| Quality of Life | 5 | 2023 | 505 | 1.020 |
Why?
|
| Depressive Disorder, Treatment-Resistant | 3 | 2022 | 6 | 1.010 |
Why?
|
| Suicidal Ideation | 5 | 2025 | 99 | 0.950 |
Why?
|
| Health Maintenance Organizations | 17 | 2012 | 403 | 0.920 |
Why?
|
| Mental Disorders | 10 | 2022 | 276 | 0.910 |
Why?
|
| Mobile Applications | 1 | 2025 | 14 | 0.880 |
Why?
|
| Child | 28 | 2026 | 2485 | 0.850 |
Why?
|
| Attitude of Health Personnel | 2 | 2025 | 204 | 0.840 |
Why?
|
| Health Personnel | 1 | 2025 | 135 | 0.800 |
Why?
|
| Serotonin Uptake Inhibitors | 5 | 2013 | 45 | 0.750 |
Why?
|
| Suicide, Attempted | 4 | 2022 | 93 | 0.740 |
Why?
|
| Delivery of Health Care, Integrated | 5 | 2023 | 540 | 0.720 |
Why?
|
| United States | 32 | 2024 | 3922 | 0.720 |
Why?
|
| Patient Acuity | 1 | 2022 | 9 | 0.720 |
Why?
|
| Cost of Illness | 3 | 2014 | 92 | 0.710 |
Why?
|
| Adult | 40 | 2025 | 7621 | 0.690 |
Why?
|
| Opioid-Related Disorders | 3 | 2014 | 185 | 0.690 |
Why?
|
| Combined Modality Therapy | 6 | 2014 | 114 | 0.680 |
Why?
|
| Substance-Related Disorders | 7 | 2020 | 417 | 0.680 |
Why?
|
| Adolescent Behavior | 3 | 2026 | 123 | 0.640 |
Why?
|
| Psychotic Disorders | 4 | 2024 | 52 | 0.590 |
Why?
|
| Patient Health Questionnaire | 3 | 2024 | 18 | 0.590 |
Why?
|
| Genetic Carrier Screening | 5 | 2018 | 16 | 0.560 |
Why?
|
| Delivery of Health Care | 5 | 2018 | 383 | 0.540 |
Why?
|
| Psychotropic Drugs | 8 | 2017 | 35 | 0.530 |
Why?
|
| Self Care | 5 | 2011 | 144 | 0.510 |
Why?
|
| Middle Aged | 28 | 2024 | 7954 | 0.510 |
Why?
|
| Patient Selection | 4 | 2020 | 181 | 0.510 |
Why?
|
| Treatment Outcome | 16 | 2026 | 1161 | 0.510 |
Why?
|
| Psychology, Adolescent | 1 | 2016 | 11 | 0.500 |
Why?
|
| Buprenorphine | 2 | 2014 | 53 | 0.500 |
Why?
|
| Psychiatric Status Rating Scales | 10 | 2026 | 107 | 0.500 |
Why?
|
| Binge-Eating Disorder | 3 | 2010 | 13 | 0.480 |
Why?
|
| Medicaid | 7 | 2013 | 188 | 0.460 |
Why?
|
| Outcome Assessment (Health Care) | 3 | 2018 | 213 | 0.440 |
Why?
|
| Health Policy | 2 | 2014 | 106 | 0.430 |
Why?
|
| Antidepressive Agents | 6 | 2018 | 142 | 0.430 |
Why?
|
| Motivation | 3 | 2023 | 112 | 0.430 |
Why?
|
| Child, Preschool | 14 | 2024 | 1455 | 0.420 |
Why?
|
| Genetic Testing | 7 | 2023 | 73 | 0.420 |
Why?
|
| Commerce | 1 | 2014 | 37 | 0.420 |
Why?
|
| Child of Impaired Parents | 6 | 2016 | 27 | 0.410 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2026 | 323 | 0.410 |
Why?
|
| Surveys and Questionnaires | 9 | 2022 | 1296 | 0.410 |
Why?
|
| Bulimia Nervosa | 3 | 2010 | 10 | 0.400 |
Why?
|
| Cyclohexanols | 4 | 2013 | 19 | 0.390 |
Why?
|
| Genetic Diseases, Inborn | 3 | 2018 | 9 | 0.380 |
Why?
|
| Retrospective Studies | 11 | 2024 | 2502 | 0.380 |
Why?
|
| Psychotherapy, Brief | 3 | 2026 | 21 | 0.380 |
Why?
|
| Parents | 6 | 2017 | 301 | 0.370 |
Why?
|
| Case-Control Studies | 9 | 2022 | 1107 | 0.370 |
Why?
|
| Bipolar Disorder | 3 | 2020 | 60 | 0.350 |
Why?
|
| Follow-Up Studies | 12 | 2019 | 1157 | 0.350 |
Why?
|
| Manuals as Topic | 2 | 2010 | 5 | 0.340 |
Why?
|
| Antipsychotic Agents | 3 | 2024 | 50 | 0.330 |
Why?
|
| Methadone | 1 | 2010 | 13 | 0.330 |
Why?
|
| Prepaid Health Plans | 1 | 2010 | 18 | 0.330 |
Why?
|
| Schizophrenia | 3 | 2024 | 76 | 0.320 |
Why?
|
| Health Care Surveys | 2 | 2017 | 210 | 0.320 |
Why?
|
| Child Health | 2 | 2023 | 43 | 0.310 |
Why?
|
| Life Style | 1 | 2012 | 321 | 0.310 |
Why?
|
| Opiate Substitution Treatment | 1 | 2010 | 55 | 0.310 |
Why?
|
| State Health Plans | 2 | 2000 | 32 | 0.310 |
Why?
|
| Overweight | 1 | 2012 | 266 | 0.310 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 5 | 2019 | 70 | 0.310 |
Why?
|
| Weight Loss | 1 | 2012 | 298 | 0.300 |
Why?
|
| Preconception Care | 4 | 2018 | 44 | 0.290 |
Why?
|
| Preventive Health Services | 3 | 2016 | 147 | 0.280 |
Why?
|
| Risk Factors | 9 | 2022 | 3291 | 0.270 |
Why?
|
| Community Mental Health Services | 3 | 2002 | 33 | 0.260 |
Why?
|
| Qualitative Research | 3 | 2025 | 290 | 0.250 |
Why?
|
| Self-Injurious Behavior | 2 | 2024 | 44 | 0.250 |
Why?
|
| Electronic Health Records | 7 | 2023 | 719 | 0.250 |
Why?
|
| Age Factors | 4 | 2020 | 874 | 0.240 |
Why?
|
| Child Behavior | 1 | 2026 | 25 | 0.240 |
Why?
|
| Health Expenditures | 4 | 2018 | 72 | 0.240 |
Why?
|
| Family Planning Services | 2 | 2016 | 20 | 0.240 |
Why?
|
| Genome, Human | 2 | 2016 | 33 | 0.240 |
Why?
|
| Young Adult | 10 | 2024 | 2538 | 0.240 |
Why?
|
| Ethnic Groups | 4 | 2019 | 443 | 0.230 |
Why?
|
| Mammography | 2 | 2023 | 173 | 0.230 |
Why?
|
| Patient Compliance | 4 | 2019 | 269 | 0.230 |
Why?
|
| Health Status | 3 | 2020 | 291 | 0.230 |
Why?
|
| Mental Health | 3 | 2023 | 163 | 0.230 |
Why?
|
| Public Health Administration | 2 | 1997 | 6 | 0.230 |
Why?
|
| Practice Patterns, Physicians' | 4 | 2013 | 308 | 0.220 |
Why?
|
| Breast Neoplasms | 2 | 2023 | 1005 | 0.220 |
Why?
|
| Telemedicine | 2 | 2026 | 196 | 0.220 |
Why?
|
| Rural Population | 1 | 2024 | 58 | 0.210 |
Why?
|
| Clozapine | 1 | 2024 | 6 | 0.210 |
Why?
|
| Vaginal Smears | 1 | 2004 | 48 | 0.210 |
Why?
|
| Community-Institutional Relations | 1 | 2004 | 43 | 0.200 |
Why?
|
| Genetic Counseling | 4 | 2016 | 27 | 0.200 |
Why?
|
| Aged | 9 | 2022 | 6223 | 0.200 |
Why?
|
| Health Services | 3 | 2015 | 110 | 0.200 |
Why?
|
| Risk Assessment | 4 | 2024 | 1093 | 0.200 |
Why?
|
| Patient Care | 1 | 2023 | 30 | 0.200 |
Why?
|
| Chronic Pain | 1 | 2024 | 133 | 0.190 |
Why?
|
| Drug Utilization | 5 | 2003 | 119 | 0.190 |
Why?
|
| Cohort Studies | 2 | 2022 | 2502 | 0.190 |
Why?
|
| Utilization Review | 3 | 2018 | 42 | 0.190 |
Why?
|
| Minority Groups | 1 | 2023 | 104 | 0.190 |
Why?
|
| Sequence Analysis, DNA | 3 | 2016 | 32 | 0.190 |
Why?
|
| Alcohol Drinking | 2 | 2004 | 354 | 0.180 |
Why?
|
| Child Abuse | 1 | 2023 | 45 | 0.180 |
Why?
|
| Natural Language Processing | 1 | 2023 | 60 | 0.180 |
Why?
|
| Venlafaxine Hydrochloride | 4 | 2013 | 20 | 0.180 |
Why?
|
| Longitudinal Studies | 4 | 2017 | 686 | 0.180 |
Why?
|
| Antidepressive Agents, Second-Generation | 2 | 2012 | 19 | 0.170 |
Why?
|
| Infant | 7 | 2024 | 1228 | 0.170 |
Why?
|
| Prevalence | 5 | 2024 | 830 | 0.170 |
Why?
|
| Sex Factors | 4 | 2020 | 599 | 0.170 |
Why?
|
| Oregon | 7 | 2006 | 172 | 0.170 |
Why?
|
| Prospective Studies | 2 | 2023 | 1251 | 0.160 |
Why?
|
| Genomics | 2 | 2018 | 56 | 0.160 |
Why?
|
| Genetic Research | 1 | 2020 | 7 | 0.160 |
Why?
|
| Social Change | 1 | 2000 | 1 | 0.160 |
Why?
|
| Behavior Control | 1 | 2000 | 3 | 0.160 |
Why?
|
| Managed Care Programs | 4 | 2010 | 300 | 0.160 |
Why?
|
| Child Behavior Disorders | 1 | 2000 | 17 | 0.160 |
Why?
|
| Models, Psychological | 1 | 2019 | 21 | 0.150 |
Why?
|
| Health Plan Implementation | 1 | 2000 | 33 | 0.150 |
Why?
|
| Benzodiazepines | 1 | 2019 | 29 | 0.150 |
Why?
|
| Sleep Wake Disorders | 1 | 2019 | 33 | 0.150 |
Why?
|
| Socioeconomic Factors | 2 | 2020 | 603 | 0.150 |
Why?
|
| Patient Participation | 1 | 2020 | 124 | 0.150 |
Why?
|
| Machine Learning | 1 | 2019 | 60 | 0.150 |
Why?
|
| Quality of Health Care | 2 | 2004 | 260 | 0.150 |
Why?
|
| Neonatal Screening | 1 | 2018 | 12 | 0.140 |
Why?
|
| Guideline Adherence | 1 | 2019 | 155 | 0.140 |
Why?
|
| Clinical Decision-Making | 1 | 2018 | 33 | 0.140 |
Why?
|
| Psychotherapy | 2 | 2016 | 56 | 0.140 |
Why?
|
| Patient Care Planning | 1 | 2018 | 45 | 0.130 |
Why?
|
| Quality-Adjusted Life Years | 3 | 2018 | 41 | 0.130 |
Why?
|
| Skin Diseases | 1 | 2017 | 10 | 0.130 |
Why?
|
| Neoplasms | 1 | 2022 | 457 | 0.130 |
Why?
|
| Decision Making | 5 | 2016 | 177 | 0.130 |
Why?
|
| State Government | 1 | 1997 | 14 | 0.130 |
Why?
|
| Health Care Rationing | 1 | 1997 | 11 | 0.130 |
Why?
|
| Drug Therapy, Combination | 2 | 2011 | 104 | 0.130 |
Why?
|
| Affective Disorders, Psychotic | 1 | 2017 | 9 | 0.130 |
Why?
|
| Interview, Psychological | 1 | 2016 | 15 | 0.130 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 57 | 0.120 |
Why?
|
| Counseling | 2 | 2015 | 173 | 0.120 |
Why?
|
| Time Factors | 5 | 2026 | 1038 | 0.120 |
Why?
|
| Truth Disclosure | 1 | 2016 | 14 | 0.120 |
Why?
|
| Body Mass Index | 2 | 2012 | 959 | 0.120 |
Why?
|
| Preimplantation Diagnosis | 1 | 2015 | 2 | 0.110 |
Why?
|
| Incidence | 3 | 2017 | 1278 | 0.110 |
Why?
|
| Insurance, Health | 1 | 2017 | 169 | 0.110 |
Why?
|
| Comorbidity | 6 | 2014 | 552 | 0.110 |
Why?
|
| Psychotherapy, Group | 3 | 2013 | 20 | 0.110 |
Why?
|
| Health Promotion | 1 | 2018 | 293 | 0.110 |
Why?
|
| Washington | 4 | 2023 | 388 | 0.110 |
Why?
|
| Cross-Sectional Studies | 4 | 2024 | 1295 | 0.110 |
Why?
|
| Drug Resistance | 2 | 2012 | 19 | 0.110 |
Why?
|
| Models, Theoretical | 1 | 2014 | 67 | 0.110 |
Why?
|
| Pneumonia | 1 | 2014 | 48 | 0.100 |
Why?
|
| Diagnostic Errors | 1 | 2014 | 29 | 0.100 |
Why?
|
| Off-Label Use | 1 | 2013 | 13 | 0.100 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 88 | 0.100 |
Why?
|
| Anorexia Nervosa | 2 | 2010 | 5 | 0.100 |
Why?
|
| Secondary Prevention | 2 | 2010 | 50 | 0.100 |
Why?
|
| Continental Population Groups | 1 | 2015 | 283 | 0.100 |
Why?
|
| Evidence-Based Medicine | 1 | 2014 | 173 | 0.100 |
Why?
|
| Drug Prescriptions | 1 | 2014 | 143 | 0.100 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 2 | 2013 | 8 | 0.100 |
Why?
|
| Research Design | 1 | 2015 | 337 | 0.100 |
Why?
|
| Financing, Organized | 1 | 1993 | 5 | 0.100 |
Why?
|
| Reproducibility of Results | 3 | 2026 | 363 | 0.100 |
Why?
|
| Population Surveillance | 1 | 2014 | 248 | 0.100 |
Why?
|
| Substance Abuse Treatment Centers | 2 | 2004 | 73 | 0.100 |
Why?
|
| Patient Readmission | 1 | 2014 | 163 | 0.090 |
Why?
|
| Myocardial Infarction | 1 | 2014 | 226 | 0.090 |
Why?
|
| Internet | 2 | 2005 | 207 | 0.090 |
Why?
|
| Program Development | 2 | 2011 | 65 | 0.090 |
Why?
|
| Anhedonia | 1 | 2012 | 4 | 0.090 |
Why?
|
| Risk | 3 | 2019 | 492 | 0.090 |
Why?
|
| Severity of Illness Index | 5 | 2013 | 446 | 0.090 |
Why?
|
| Parent-Child Relations | 1 | 2012 | 55 | 0.090 |
Why?
|
| Bulimia | 1 | 2011 | 8 | 0.090 |
Why?
|
| Referral and Consultation | 2 | 2017 | 161 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2023 | 384 | 0.080 |
Why?
|
| Analgesics, Opioid | 1 | 2013 | 258 | 0.080 |
Why?
|
| Cost Savings | 1 | 2010 | 20 | 0.080 |
Why?
|
| Diet | 1 | 2012 | 355 | 0.080 |
Why?
|
| Sensitivity and Specificity | 2 | 2015 | 302 | 0.080 |
Why?
|
| Health Behavior | 1 | 2012 | 348 | 0.080 |
Why?
|
| Self-Help Groups | 1 | 2009 | 27 | 0.070 |
Why?
|
| Heart Failure | 1 | 2014 | 414 | 0.070 |
Why?
|
| Psychometrics | 3 | 2017 | 119 | 0.070 |
Why?
|
| Central Nervous System Stimulants | 2 | 2017 | 28 | 0.070 |
Why?
|
| Focus Groups | 3 | 2016 | 144 | 0.070 |
Why?
|
| Health Services Research | 3 | 2018 | 201 | 0.070 |
Why?
|
| Infant, Newborn | 2 | 2023 | 842 | 0.070 |
Why?
|
| Feeding and Eating Disorders | 1 | 2007 | 16 | 0.070 |
Why?
|
| Exercise | 1 | 2012 | 538 | 0.060 |
Why?
|
| Northwestern United States | 3 | 2017 | 53 | 0.060 |
Why?
|
| Terminology as Topic | 2 | 2016 | 15 | 0.060 |
Why?
|
| Exome | 2 | 2016 | 21 | 0.060 |
Why?
|
| Health Resources | 1 | 2026 | 39 | 0.060 |
Why?
|
| Heterozygote | 2 | 2016 | 30 | 0.060 |
Why?
|
| Incidental Findings | 2 | 2016 | 28 | 0.060 |
Why?
|
| Interviews as Topic | 3 | 2018 | 324 | 0.060 |
Why?
|
| Logistic Models | 3 | 2019 | 866 | 0.050 |
Why?
|
| Pain Management | 1 | 2024 | 58 | 0.050 |
Why?
|
| Physical Fitness | 1 | 2004 | 68 | 0.050 |
Why?
|
| Ambulatory Care | 2 | 2018 | 228 | 0.050 |
Why?
|
| Pragmatic Clinical Trials as Topic | 1 | 2024 | 65 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2023 | 3 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 2013 | 28 | 0.050 |
Why?
|
| Citalopram | 1 | 2013 | 9 | 0.050 |
Why?
|
| Behavioral Symptoms | 1 | 2013 | 4 | 0.050 |
Why?
|
| Fluoxetine | 1 | 2013 | 17 | 0.050 |
Why?
|
| Remission Induction | 1 | 2013 | 26 | 0.050 |
Why?
|
| Paroxetine | 1 | 2013 | 14 | 0.050 |
Why?
|
| Veterans | 1 | 2024 | 149 | 0.050 |
Why?
|
| Drug Utilization Review | 1 | 2003 | 22 | 0.050 |
Why?
|
| Women's Health | 1 | 2004 | 198 | 0.050 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2003 | 31 | 0.050 |
Why?
|
| Gender Identity | 1 | 2002 | 37 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2023 | 85 | 0.050 |
Why?
|
| Germ-Line Mutation | 1 | 2022 | 20 | 0.050 |
Why?
|
| Adjustment Disorders | 1 | 2002 | 2 | 0.050 |
Why?
|
| Mastectomy | 1 | 2022 | 34 | 0.050 |
Why?
|
| Pregnancy | 2 | 2018 | 1565 | 0.040 |
Why?
|
| Biological Specimen Banks | 1 | 2020 | 11 | 0.040 |
Why?
|
| Methylphenidate | 1 | 2000 | 3 | 0.040 |
Why?
|
| California | 2 | 2017 | 2433 | 0.040 |
Why?
|
| Models, Organizational | 1 | 2000 | 54 | 0.040 |
Why?
|
| Oceanic Ancestry Group | 1 | 2019 | 32 | 0.040 |
Why?
|
| Indians, North American | 1 | 2019 | 48 | 0.040 |
Why?
|
| Mentoring | 1 | 2019 | 29 | 0.040 |
Why?
|
| Asian Americans | 1 | 2019 | 160 | 0.040 |
Why?
|
| Religion and Medicine | 1 | 2018 | 2 | 0.040 |
Why?
|
| Hospitalization | 1 | 2024 | 831 | 0.040 |
Why?
|
| Reproductive Health | 1 | 2018 | 10 | 0.030 |
Why?
|
| Income | 1 | 2018 | 86 | 0.030 |
Why?
|
| Self Report | 1 | 2019 | 262 | 0.030 |
Why?
|
| Intention to Treat Analysis | 1 | 2018 | 19 | 0.030 |
Why?
|
| Personality Assessment | 2 | 2012 | 11 | 0.030 |
Why?
|
| Patient Admission | 1 | 2018 | 69 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2023 | 559 | 0.030 |
Why?
|
| Hispanic Americans | 1 | 2019 | 370 | 0.030 |
Why?
|
| European Continental Ancestry Group | 1 | 2019 | 470 | 0.030 |
Why?
|
| Practice Guidelines as Topic | 1 | 2019 | 319 | 0.030 |
Why?
|
| Health Services Accessibility | 1 | 2000 | 269 | 0.030 |
Why?
|
| Least-Squares Analysis | 1 | 1997 | 13 | 0.030 |
Why?
|
| Ohio | 1 | 1997 | 23 | 0.030 |
Why?
|
| Atomoxetine Hydrochloride | 1 | 2017 | 3 | 0.030 |
Why?
|
| Adrenergic Uptake Inhibitors | 1 | 2017 | 4 | 0.030 |
Why?
|
| Financing, Government | 1 | 1997 | 25 | 0.030 |
Why?
|
| African Americans | 1 | 2019 | 429 | 0.030 |
Why?
|
| Taxes | 1 | 1997 | 23 | 0.030 |
Why?
|
| Patient Reported Outcome Measures | 1 | 2016 | 46 | 0.030 |
Why?
|
| Colorado | 1 | 2017 | 170 | 0.030 |
Why?
|
| Treatment Refusal | 1 | 2016 | 30 | 0.030 |
Why?
|
| Emergency Medical Services | 1 | 2016 | 44 | 0.030 |
Why?
|
| Causality | 1 | 2016 | 35 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2016 | 193 | 0.030 |
Why?
|
| Family | 1 | 2016 | 111 | 0.030 |
Why?
|
| Attitude to Health | 1 | 2015 | 147 | 0.030 |
Why?
|
| Medical Records, Problem-Oriented | 1 | 2014 | 3 | 0.030 |
Why?
|
| Insurance Claim Reporting | 1 | 2014 | 6 | 0.030 |
Why?
|
| Single-Blind Method | 1 | 2013 | 40 | 0.030 |
Why?
|
| Needs Assessment | 1 | 2014 | 66 | 0.030 |
Why?
|
| Hospitals, State | 1 | 1993 | 1 | 0.020 |
Why?
|
| Foundations | 1 | 1993 | 7 | 0.020 |
Why?
|
| Reimbursement, Incentive | 1 | 1993 | 21 | 0.020 |
Why?
|
| Urban Health | 1 | 1993 | 36 | 0.020 |
Why?
|
| Drug Substitution | 1 | 2012 | 8 | 0.020 |
Why?
|
| Pilot Projects | 1 | 1993 | 214 | 0.020 |
Why?
|
| Affect | 1 | 2012 | 21 | 0.020 |
Why?
|
| Double-Blind Method | 1 | 2012 | 144 | 0.020 |
Why?
|
| Adolescent Health Services | 1 | 2001 | 40 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 80 | 0.020 |
Why?
|
| Psychopathology | 1 | 2010 | 4 | 0.020 |
Why?
|
| Personality Inventory | 1 | 2010 | 12 | 0.020 |
Why?
|
| Social Adjustment | 1 | 2010 | 13 | 0.020 |
Why?
|
| Body Image | 1 | 2010 | 21 | 0.020 |
Why?
|
| Chronic Disease | 1 | 1993 | 398 | 0.020 |
Why?
|
| Child Health Services | 1 | 2001 | 107 | 0.020 |
Why?
|
| Feeding Behavior | 1 | 2010 | 163 | 0.020 |
Why?
|
| Office Visits | 1 | 2007 | 75 | 0.020 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2007 | 73 | 0.020 |
Why?
|
| Cost Control | 1 | 2006 | 13 | 0.020 |
Why?
|
| Observer Variation | 1 | 2005 | 36 | 0.010 |
Why?
|
| Cues | 1 | 2005 | 9 | 0.010 |
Why?
|
| Recurrence | 1 | 2005 | 166 | 0.010 |
Why?
|
| Telephone | 1 | 2005 | 159 | 0.010 |
Why?
|
| Weight Gain | 1 | 2005 | 165 | 0.010 |
Why?
|
| Case Management | 1 | 2004 | 29 | 0.010 |
Why?
|
| Analysis of Variance | 1 | 2004 | 137 | 0.010 |
Why?
|
| Algorithms | 1 | 2005 | 227 | 0.010 |
Why?
|
| Family Relations | 1 | 2003 | 16 | 0.010 |
Why?
|
| Retention (Psychology) | 1 | 2002 | 5 | 0.010 |
Why?
|
| Patient Dropouts | 1 | 2002 | 20 | 0.010 |
Why?
|
| Sex Distribution | 1 | 2003 | 174 | 0.010 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2003 | 67 | 0.010 |
Why?
|
| Age Distribution | 1 | 2003 | 230 | 0.010 |
Why?
|
| Databases, Factual | 1 | 2002 | 304 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2002 | 193 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 1976 | 0.010 |
Why?
|